Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jan;23(1):96-109.
doi: 10.1002/lt.24640.

Biliary atresia: Indications and timing of liver transplantation and optimization of pretransplant care

Affiliations
Review

Biliary atresia: Indications and timing of liver transplantation and optimization of pretransplant care

Shikha S Sundaram et al. Liver Transpl. 2017 Jan.

Abstract

Biliary atresia (BA) is a progressive, fibro-obliterative disorder of the intrahepatic and extrahepatic bile ducts in infancy. The majority of affected children will eventually develop end-stage liver disease and require liver transplantation (LT). Indications for LT in BA include failed Kasai portoenterostomy, significant and recalcitrant malnutrition, recurrent cholangitis, and the progressive manifestations of portal hypertension. Extrahepatic complications of this disease, such as hepatopulmonary syndrome and portopulmonary hypertension, are also indications for LT. Optimal pretransplant management of these potentially life-threatening complications and maximizing nutrition and growth require the expertise of a multidisciplinary team with experience caring for BA. The timing of transplant for BA requires careful consideration of the potential risk of transplant versus the survival benefit at any given stage of disease. Children with BA often experience long wait times for transplant unless exception points are granted to reflect severity of disease. Family preparedness for this arduous process is therefore critical. Liver Transplantation 23:96-109 2017 AASLD.

PubMed Disclaimer

References

    1. Sokol RJ, Shepherd RW, Superina R, Bezerra JA, Robuck P, Hoofnagle JH. Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop. Hepatology. 2007;46:566–581. - PMC - PubMed
    1. Hitch DC, Shikes RH, Lilly JR. Determinants of survival after Kasai’s operation for biliary atresia using actuarial analysis. J Pediatr Surg. 1979;14:310–314. - PubMed
    1. Lilly JR, Karrer FM, Hall RJ, Stellin GP, Vasquez-Estevez JJ, Greenholz SK, Wanek EA, et al. The surgery of biliary atresia. Ann Surg. 1989;210:289–294. discussion 294-286. - PMC - PubMed
    1. Altman RP, Lilly JR, Greenfeld J, Weinberg A, van Leeuwen K, Flanigan L. A multivariable risk factor analysis of the portoenterostomy (Kasai) procedure for biliary atresia: twenty-five years of experience from two centers. Ann Surg. 1997;226:348–353. discussion 353-345. - PMC - PubMed
    1. Shneider BL, Brown MB, Haber B, Whitington PF, Schwarz K, Squires R, Bezerra J, et al. A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr. 2006;148:467–474. - PubMed

Publication types

MeSH terms